ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1630

Patient-Reported Fatigue Associated with Joint Histopathology in Rheumatoid Arthritis

Diyu Fisher1, Dana Orange2, Melanie Smith3, Bella Mehta4, Edoardo Spolaore5, Edward DiCarlo3, Dongmei Sun3, Laura Donlin3 and Susan Goodman3, 1Stony Brook Medicine, Port Jefferson Station, NY, 2The Rockefeller University, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5HSS, New York, NY

Meeting: ACR Convergence 2023

Keywords: Fatigue, Inflammation, Pathology Bone Joint, rheumatoid arthritis, Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Comorbidities

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Fatigue or tiredness is an important symptom for patients with rheumatoid arthritis (RA), yet the factors associated with fatigue are poorly understood and may differ between patients with low vs. high disease activity. We sought to explore whether patient-reported fatigue is associated with histologic changes in the synovium in both low and high disease activity patients.

Methods: 152 patients meeting ACR/EULAR 1987 and/or 2010 RA criteria were recruited prior to elective total joint replacement. At a pre-operative visit, patients were given questionnaires to assess global function and RA disease activity. Patient reported fatigue (“How much of a problem has unusual FATIGUE or TIREDNESS been for you in the PAST WEEK?”) was rated by patients on a 0-10 scale and stratified into mild (0-3), moderate (4-7), or severe (8-10). Patients were also asked how they dealt with depression/feeling blue and nervousness/anxiety over the last week through the Multi-Dimensional Health Assessment Questionnaire (MDHAQ). Demographics, RA characteristics, tender and swollen joints to measure disease activity, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were collected. Hematoxylin and eosin (H&E) stains were prepared from the synovium of the operative joint and 10 characteristics were systematically scored by a pathologist as previously described. Relationships between patient fatigue and studied variables were measured with Kendall’s Tau and compared in patients with high (DAS28>3.2) vs low (DAS28< 3.2) disease activity. Backward stepwise selection and multivariable ordered logistic regression were used to study the association of patient fatigue with other variables.

Results: Of the 152 patients in the study, 86.2% were women, with age 62.7 (±11.4) (mean±SD) years old, disease duration 14.75 (±12.4) years, and DAS28 3.87 (±1.30), indicating overall moderate disease activity. Among mild, moderate, and severe fatigue groups, there were no differences in comorbidities, such as history of diagnosed mental illness, anemia, fibromyalgia, thyroid disease, and cancer (Table 1). However, patients with higher fatigue reported higher recent anxiety and depression. Fatigue was correlated with DAS28, synovial lymphocytic inflammation (SLI), synovial lining hyperplasia, recent anxiety, recent depression, RA pain, and global pain (Figure 1). Of the patients with low disease activity, 46.5% had moderate, marked, or band-like SLI. In multivariable models, fatigue was significantly associated with SLI in low diseases activity patients (1.92[1.09,3.57]; p=0.024) but not with recent anxiety or depression. In high disease activity patients, fatigue was associated with anxiety and synovial lining hyperplasia (1.57[1.01,2.5]; p=0.047) but no other synovial histopathologic features.

Conclusion: In patients with low disease activity, fatigue is associated with chronic lymphocytic joint inflammation but not with anxiety or depression, suggesting an association with subclinical synovitis. In contrast, in RA patients with high disease activity, fatigue is associated with anxiety and synovial lining hyperplasia but not chronic lymphocytic inflammation.

Supporting image 1

1 = median(IQR); 2=n(%); 3=mean(SD)
**Questions from the Multi-Dimensional Health Assessment Questionnaire:
Over the last week, were you able to:
Deal with feelings of anxiety or being nervous?
Deal with feelings of depression or feeling blue?
0, Without any difficulty | 1, With some difficulty | 2, With much difficulty | 3, Unable to do
BMI = body mass index; DAS28 = disease activity score using 28 joints; RF = rheumatoid factor; CCP = cyclic citrullinated protein; ESR=erythrocyte sedimentation rate; CRP=C Reactive Protein;
Bolded values significant p<0.05

Supporting image 2

Size/color of circle indicates strength of association between 2 variables using Kendall’s tau, with significance set at P<0.1, otherwise “X” added

Supporting image 3


Disclosures: D. Fisher: None; D. Orange: AstraZeneca, 2, Pfizer, 2; M. Smith: None; B. Mehta: Janssen, 1, Novartis, 5; E. Spolaore: None; E. DiCarlo: None; D. Sun: None; L. Donlin: Bristol-Myers Squibb(BMS), 2, Stryker, 2; S. Goodman: NIH, 5, Novartis, 5.

To cite this abstract in AMA style:

Fisher D, Orange D, Smith M, Mehta B, Spolaore E, DiCarlo E, Sun D, Donlin L, Goodman S. Patient-Reported Fatigue Associated with Joint Histopathology in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/patient-reported-fatigue-associated-with-joint-histopathology-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-fatigue-associated-with-joint-histopathology-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology